During the past decade, Solaris Clinical Research conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 19 clinical trials were completed, i.e. on average, 79.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Solaris Clinical Research" #1 sponsor was "Pfizer" with 11 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "BioNTech SE" with 5 trials sponsored, "Intarcia Therapeutics" with 3 trials sponsored and "Kowa Research Institute, Inc." with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Solaris Clinical Research" #1 collaborator was "Pfizer" with 5 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Solaris Clinical Research" are "COVID-19" (5 trials), "SARS-CoV-2 Infection" (5 trials), "Diabetes Mellitus, Type 2" (3 trials), "Hyperlipidemia" (3 trials) and "Obesity" (3 trials). Many other conditions were trialed in "Solaris Clinical Research" in a lesser frequency.

Most popular intervention types in "Solaris Clinical Research" are "Drug" (20 trials), "Biological" (10 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "BNT162b2" (5 trials), "Tirzepatide" (4 trials), "Dulaglutide" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Solaris Clinical Research" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Solaris Clinical Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Solaris Clinical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Solaris Clinical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".